CENTOGENE to Participate in Upcoming Conferences in April
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 14, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life...
News
Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis
Favorable safety and tolerability profile related to OCU400 investigational product candidateInitial clinical data from low and medium dose cohorts indicates...
Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28
Company financials to be filed after market on April 27, 2023, and operational outlook to be provided during call, including...
Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
TransCode Therapeutics Announces Equity Investment from White Lion Capital to Help Fund Development of TTX-MC138 for Treatment of Glioblastomas
BOSTON, April 14, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™...
Aesthetic Medical International to Announce FY2022 Annual Report on April 21, 2023
SHENZHEN, China, April 14, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”),...
QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023
Launch of cell-free DNA (cfDNA) next-generation sequencing kits to test liquid biopsies // Study to demonstrate QIAGEN’s expertise in detecting...
ITM lädt zu Symposium und Messestand auf der Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig ein
Garching / München, 14. April 2023 – ITM Isotope Technologies Munich SE (ITM), ein führendes radiopharmazeutisches Biotech-Unternehmen, nimmt an der 61. Jahrestagung...
Editas Medicine Strengthens Board of Directors with Appointment of New Chair and New Director
Elliott Levy, M.D. Editas Medicine announced the appointment of Elliott Levy, M.D., to its Board of Directors as an independent...
Imprivata Launches First Digital Identity Maturity Model and Assessment Developed for Healthcare IT, Security, and Clinical Leadership
Free, one-of-a-kind resources deliver actionable guidance to build a comprehensive digital identity strategy that improves care quality, reduces cyber risks,...
Lisa Martinson Joins Vistant as Finance Controller
Accounting Leader Brings 30 Years of Government Contracting ExperienceTOWSON, Md., April 13, 2023 (GLOBE NEWSWIRE) -- Vistant, a Maryland-based firm...
Michael Blackton Appointed as Senior Vice President of Elektrofi’s Technical Operations as Elektrofi Continues to Bolster Leadership Bench with Industry Veterans
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) -- Today Elektrofi, a biotechnology company focused on drug formulation and delivery innovations, welcomed...
First in Minnesota: Park Nicollet Methodist Hospital Incorporates New State-of-the-Art Breast Cancer Treatment
EnVisio Surgical Navigation System and SmartClip Technology Improves Clinical and Cosmetic Outcomes for Breast Cancer Surgery patients EnVisio Surgical Navigation EnVisio...
Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses
Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic preclinical...
Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
REDWOOD CITY, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage...
Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy
BlueCross BlueShield of Mississippi Latest to Allow Non-Physician Practitioners to Prescribe TMSMALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics,...
Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism
OncoBay Clinical is a boutique clinical research organization (CRO) that is a subsidiary of the Moffitt Cancer Center and has...
SCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) April 15-18 in Denmark
JERSEY CITY, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Galecto to Present Two Posters at AACR Annual Meeting 2023
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin...